secwatch.observer — SEC 8-K summary
======================================

Issuer:     Atea Pharmaceuticals, Inc. (AVIR)
CIK:        0001593899
Form:       8-K
Filed at:   2025-03-24T23:59:59+00:00
Accession:  0001193125-25-060794
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Atea Pharmaceuticals receives director nominations from two stockholders for 2025 Annual Meeting
--------------------------------------------------------------------------------

- Bradley L. Radoff nominates Howard H. Berman, James P. Flynn, and Michael Torok.
- Driver Opportunity Partners III LP nominates J. Abbott R. Cooper for election.
- Nominating Committee will evaluate candidates; formal recommendation in proxy statement.
- No shareholder action required now; 2025 Annual Meeting date not yet scheduled.
- Evercore and Latham & Watkins retained as financial and legal advisors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1593899/000119312525060794/0001193125-25-060794-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1593899/000119312525060794/d932774d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-060794

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer